Search:

Exact Keyword


Total 593 results.
Sort by Relevant
Opportunities in Heart Valve Disease Management: Europe, Japan and Rest of World (2005)
548 Pages | 147 Exhibits | 2005 Analysis | Forecasts Through | Relavancy 1
Although Europe and Japan have large, aging populations subject to degenerative heart conditions, and the developing nations continue to have sizeable populations with rheumatic heart disease, these individuals are much less likely to undergo surgical treatment of their valve disease than in the U.S. The highly invasive nature of valve surgery, high product costs, and the fact that, in many cases, heart valv...[Read More]




U.S. Opportunities in the Management of Urinary Incontinence (2005)
594 Pages | 177 Exhibits | 2005 Analysis | Forecasts Through | Relavancy 1
Recent epidemiological data indicate that urinary incontinence (UI) affects an astounding 34 million Americans, and 38 million are affected by overactive bladder (OAB). Roughly one-third of patients experience significant symptoms that may prompt them to seek treatment. Unfortunately, therapeutic options have been largely limited to the extremes of medical management or invasive surgery, creating significant undertreatment of this devastating, but not life-threatening condition. ...[Read More]




U.S. Markets for Cardiovascular Disease Diagnostic Products (2004)
382 Pages | 102 Exhibits | 2004 Analysis | Forecasts Through 2007 | Relavancy 1
More adults in the U.S. die from cardiovascular diseases/disorders than from any other cause. Nationwide, approximately 64.4 million people have at least one cardiovascular condition; these diseases/disorders kill nearly 2,600 people in the U.S. each day, and result in direct and indirect costs that exceed $368.0 billion annually. In 2003, more than 154.7 million electrocardiography, endovascular, noninvasive diagnostic imaging, and near patient in vitro testing procedures were performed...[Read More]




Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Technologies (2004)
324 Pages | 68 Exhibits | 2004 Analysis | Forecasts Through 2008 | Relavancy 1
In the United States (U.S.), cardiovascular disease afflicts more than a quarter of the population, causes more than 5 million hospitalizations, and claims nearly 1 million lives each year; additionally, more than $300 billion in healthcare expenditures are incurred annually. A major portion of these expenditures is associated with the management of the most prevalent acute and chronic myocardial conditions, such as debilitating drug-refractory angina pectoris, congestive heart failure, isch...[Read More]




U.S. Markets for Home Healthcare Products (2004)
300 Pages | 85 Exhibits | 2004 Analysis | Forecasts Through 2012 | Relavancy 1
The expense and reduced length of acute care hospital stays, the availability and evolution of new healthcare technologies, the aging of the U.S. population, and the fact that most patients prefer to be treated in their homes rather than in hospitals or skilled nursing facilities, are all driving forces in the expansion of the U.S. home healthcare products and services market. In addition to the services of home healthcare agencies, the home-based treatment of patients who are chronicall...[Read More]




European Markets for Orthopedic Implants and Trauma Products (2004)
416 Pages | 188 Exhibits | 2004 Analysis | Forecasts Through 2008 | Relavancy 1
The European orthopedic implants and trauma products market consists of reconstruction and replacement products for the hip, knee, shoulder, and small joints, as well as fracture fixation and bone growth stimulation products, bone graft substitutes and growth factors, and bone cements. In 2003, this market totaled more than $1.4 billion; key market drivers include surgeon acceptance of innovative technologies with medical-based evidence, orthopedic products receiving reimbursement code listi...[Read More]




U.S. Markets for Critical Care Patient Monitoring Products (2004)
195 Pages | 55 Exhibits | 2004 Analysis | Forecasts Through 2012 | Relavancy 1
Critical care units are the most expensive sites in the U.S. healthcare system, accounting for 30% to 40% of an acute care hospital's total budget. Despite the costs involved, critical care is one of the fastest-growing specialties in healthcare, as hospitals continue to assign an increasing proportion of their beds to patients with life-threatening conditions who require significant levels of monitoring and specialized care. Factors such as the growing acuity of hospital inpatients, th...[Read More]




U.S. Markets for General and Pelvic Endoscopic Surgery Products (2004)
418 Pages | 146 Exhibits | 2004 Analysis | Forecasts Through 2013 | Relavancy 1
In the U.S., more than 5 million general and pelvic endoscopic surgical procedures were performed in 2003. The advantages of endoscopic surgery over open surgery include lower overall treatment costs, reduced patient trauma, shorter hospital stays, and faster recovery times. These benefits have resulted in the conversion of many types of open surgery procedures to endoscopic procedures, a continuing trend that is being driven by advancements in the array of endoscopic surgery products that ...[Read More]




The U.S. Aesthetics Marketplace (2004)
181 Pages | 38 Exhibits | 2004 Analysis | Forecasts Through 2012 | Relavancy 1
In 2002, approximately 6.6 million people in the United States underwent cosmetic surgical and nonsurgical procedures, generating more than $861 million in associated product sales. Cosmetic procedures are rapidly gaining popularity among the baby boomer generation; as a result, sales are expected to experience a robust increase over the forecast period covered by this report. This report by Medtech Insight analyzes major market segments for aesthetic products, including topical aesthe...[Read More]




U.S. Opportunities in Heart Failure Technologies (2004)
560 Pages | 168 Exhibits | 2004 Analysis | Forecasts Through | Relavancy 1
Heart failure is a complex, clinical syndrome characterized by multiple causes, symptoms and presentations, but which continues to be managed almost exclusively by drug therapy. The large patient caseload (estimated at 5 million Americans and growing with demographics) coupled with the progressive nature of the disease, has generated substantial interest in new, device-based treatments, many of which are at ...[Read More]




U.S. Opportunities in the Management of Benign Uterine Conditions (2004)
305 Pages | 97 Exhibits | 2004 Analysis | Forecasts Through | Relavancy 1
Benign uterine conditions (predominantly fibroids, polyps, endometriosis, adenomyosis and menorrhagia) affect upwards of 25% of women of childbearing age in the U.S. Although most are asymptomatic, 2.6 million women seek medical treatment for these conditions annually. Therapy has traditionally relied on two extremes: medical management, comprising oral contraceptives, progestins and GnRH agonist...[Read More]




U.S. Opportunities in Osteoporosis Management (2004)
399 Pages | 116 Exhibits | 2004 Analysis | Forecasts Through | Relavancy 1
Osteoporosis affects an estimated 15 million Americans, predominantly postmenopausal women, with an additional 30 million considered at risk for the disease. Unfortunately, most patients are not diagnosed until they experience a fracture, as osteoporosis lacks distinct symptoms, had limited treatment options until recently, and is not considered a life-threatening condition. Thus, despite incre...[Read More]




U.S. Opportunities in Drug Delivery Technologies (2004)
814 Pages | 170 Exhibits | 2004 Analysis | Forecasts Through | Relavancy 1
The U.S. drug delivery market is entering a watershed period. Traditional infusion products will remain the mainstay of hospital-based healthcare; however, even with gains in implantable, insulin and disposable pumps, overall growth in this mature segment will be modest. In contrast, emerging, non-infusion drug delivery technologies are poised for significant growth as they enable the delivery ...[Read More]




U.S. Markets for Stroke Management Products (2004)
301 Pages | 65 Exhibits | 2004 Analysis | Forecasts Through 2008 | Relavancy 1
Stroke--a sudden and often catastrophic disruption in the delivery of oxygen and nutrients to the tissues of the brain--is the third-leading cause of death in the U.S., following heart disease and cancer. It is estimated that there will be 282,000 fatalities due to stroke in 2004, half of which will occur outside a hospital. Products used to manage stroke patients include diagnostic imaging systems, pharmaceuticals, and surgical and interventional systems. The U.S. market for these produ...[Read More]




Trends and Opportunities in U.S. Orthopedic Markets for Implant, Reconstruction, and Trauma Products (2004)
360 Pages | 96 Exhibits | 2004 Analysis | Forecasts Through 2012 | Relavancy 1
According to the American Academy of Orthopedic Surgeons, approximately 28.6 million people in the United States sustain some type of musculoskeletal injury annually, at a cost of approximately $254 billion. Many orthopedic reconstruction and trauma device manufacturers have experienced significant growth in the past several years. This robust growth is due to a number of factors including demographics and the aging population, improved technologies, and upward pricing of implants and devi...[Read More]




U.S. Markets for Critical Care Patient Management Products (2004)
414 Pages | 122 Exhibits | 2004 Analysis | Forecasts Through 2012 | Relavancy 1
Critical care units are the most expensive sites in the U.S. healthcare system, accounting for 30% to 40% of an acute care hospital's total budget. Despite the costs involved, critical care is one of the fastest-growing specialties in healthcare, as hospitals continue to assign an increasing proportion of their beds to patients with life-threatening conditions who require significant levels of monitoring and specialized care. Factors such as the growing acuity of hospital inpatients, th...[Read More]




Current and Emerging Wound Closure Products and Techniques in Europe and the U.S. (2003)
253 Pages | 62 Exhibits | 2003 Analysis | Forecasts Through 2007 | Relavancy 1
In an effort to address the major barriers to the adoption of minimally invasive techniques in wound closure, manufacturers and researchers alike are racing to develop sutureless methods for wound closure. As a result, a variety of endoscopic suturing devices, energy-based technologies, and glues and sealants have appeared on the market in recent years. As the appropriate regulatory bodies worldwide approve more innovative products, dramatic changes may be seen in the segmentation of the wo...[Read More]




U.S. Markets for Sports Medicine Devices and Products (2003)
262 Pages | 87 Exhibits | 2003 Analysis | Forecasts Through 2010 | Relavancy 1
Each year, approximately 30 million children participate in organized sports and 150 million adults participate in non-work-related sports or recreational activities in the United States. Although these activities are generally beneficial to one\'s health, they do involve the risk of injury. According to the Centers for Disease Control and Prevention, approximately 4.3 million sports- and recreation-related injuries are treated in U.S. hospital emergency rooms annually. In 2001, the sports...[Read More]




Pharmacological and Device-Based Therapeutic Approaches to Breast Disease (2003)
443 Pages | 51 Exhibits | 2003 Analysis | Forecasts Through 2011 | Relavancy 1
In spite of major advances in early detection and adjuvant therapy, breast cancer, especially advanced-stage disease, remains a major clinical and human problem. There is an urgent need for new therapies and novel agents that are more effective than those currently available for the treatment of advanced breast cancer and will improve the survival rates and improve quality of life for patients. There are three principal approaches to the treatment of this disease: surgery, radiotherapy, an...[Read More]




Pharmacological and Device-Based Therapeutic Approaches to Cancer Management (2003)
361 Pages | 61 Exhibits | 2003 Analysis | Forecasts Through 2007 | Relavancy 1
In 2003, an estimated 1.3 million people in the U.S. will be diagnosed with cancer and 1 in 4 deaths will be due to the disease. In addition to the tragic human toll, the cost of fighting cancer exceeds $171 billion annually in the U.S.; of this, more than $12 billion is spent on sophisticated products to treat the disease and manage its complications and side effects. These products include anticancer drugs and biopharmaceuticals; radiotherapy and photodynamic therapy products, cryoablatio...[Read More]




Opportunities in U.S. Spinal Fusion Markets (2003)
621 Pages | 158 Exhibits | 2003 Analysis | Forecasts Through | Relavancy 1
The U.S. spine market has experienced a decade of double-digit growth with expanded use of spinal fusion to treat severe, degenerative disc disease. The next decade will be even more exciting as continued, substantial market gains reflect true clinical advances in spine technologies, including prosthetic discs and nucleus replacement products, minimally invasive spinal fusion technologies, bone morphogenic proteins, intradiscal thermal therapies, an...[Read More]




Opportunities in U.S. Peripheral Vascular Stent Markets (2003)
367 Pages | 75 Exhibits | 2003 Analysis | Forecasts Through | Relavancy 1
The overwhelming success of stenting in the coronary arteries has created strong interest in applying the technology to the peripheral vasculature, and the potential in those applications is significant. However, the opportunities are neither evenly distributed across the various applications nor are they necessarily similar in nature. While the use of drug eluting stents (DES) will be focused on specific in...[Read More]




U.S. Markets for Point-of-Care Diagnostics (2003)
232 Pages | 58 Exhibits | 2003 Analysis | Forecasts Through 2006 | Relavancy 1
Point-of-care diagnostic technology includes portable, instrument-based diagnostic devices used in near-patient hospital and alternate care settings. In 2001, U.S. sales of point-of-care diagnostic devices totaled approximately $2.8 billion and are expected to increase over the forecast period covered by this report. This report by Medtech Insight analyzes major market segments for point-of-care products used in the hospital setting and at alternate care sites. These market segments includ...[Read More]




U.S. Markets for Diagnostic Oncology Products (2003)
333 Pages | 75 Exhibits | 2003 Analysis | Forecasts Through 2007 | Relavancy 1
It is estimated that 1.3 million people in the U.S. will be diagnosed with cancer in 2003, and that 1 in 4 deaths will be due to the disease. In the fight against cancer, which is the second-leading cause of death in the U.S. after heart disease, remarkable advancements have been made in developing sophisticated tools to detect malignancies at their earliest and most treatable stages. In 2002, more than 172.5 million cancer screening and diagnostic procedures were performed utilizing ima...[Read More]




European Critical Care: Markets, Trends, and Opportunities in Patient Monitoring Products (2003)
179 Pages | 53 Exhibits | 2003 Analysis | Forecasts Through 2007 | Relavancy 1
Healthcare issues affecting the European critical care industry include managed care, personnel shortages, and new approaches to product evaluation and purchasing. Underlying these issues is the persistent increasing cost of healthcare. In 2001, the European patient monitoring products market (including hemodynamic, level-of-consciousness, neurological, and vital signs monitoring products) totaled $817 million and is expected to increase over the forecast period covered by this report. Thi...[Read More]




U.S. Markets for Infection Control and Biosafety Products (2003)
261 Pages | 76 Exhibits | 2003 Analysis | Forecasts Through 2010 | Relavancy 1
Infectious diseases are the leading cause of death worldwide and the third-leading cause of death in the United States. Infectious diseases can affect any body system, be classified as acute or chronic, occur with or without fever, strike any age group, and exist concurrently with one another. Bacteria, parasites, and viruses are among the organisms that cause infectious diseases, many of which have only recently been identified. Although handwashing, medical waste disposal, and the use of...[Read More]




U.S. Markets for Dental Implants and Dental Bone Substitutes (2003)
174 Pages | 34 Exhibits | 2003 Analysis | Forecasts Through 2011 | Relavancy 1
In 2002, the dental implants and dental bone substitutes market totaled approximately $296.5 million. Over the forecast period covered by this report, sales are expected to increase significantly, reaching nearly $1.0 billion in 2011. The market will be driven by the aging of the population, technological advances, public acceptance of the techniques, and an increasing number of dental general practitioners and specialists incorporating implantation and bone substitution into their practice...[Read More]




U.S. Opportunities in Prostate Disease Management (2003)
479 Pages | 97 Exhibits | 2003 Analysis | Forecasts Through | Relavancy 1
Prostate disease--encompassing prostate cancer, benign prostatic hyperplasia (BPH) and prostatitis--continues to account for more than one-half of the average urologist\'s practice. While pharmaceuticals and prostate brachytherapy have seriously eroded prostate surgery caseloads, new opportunities in less invasive, largely office-based modalities are promising to revitalize device-based prostate interventions...[Read More]




U.S. Markets for Adjunctive and Non-Fusion Spine Technologies (2003)
490 Pages | 125 Exhibits | 2003 Analysis | Forecasts Through | Relavancy 1
The U.S. spine market has experienced a decade of double-digit growth with expanded use of spinal fusion to treat severe, degenerative disc disease. The next decade will be even more exciting as continued, substantial market gains reflect true clinical advances in spine technologies, including prosthetic discs and nucleus replacement products, minimally invasive spinal fusion technologies, bone morphogenic proteins, intradiscal thermal therapies, an...[Read More]




Opportunities in European Spinal Product Markets (2003)
563 Pages | 168 Exhibits | 2003 Analysis | Forecasts Through | Relavancy 1
Although Europe has a large, aging population subject to degenerative spine disease, the European spine market has failed to match the dramatic growth seen in the U.S. Inadequate surgeon training, unreliable fusion outcomes, expensive products, reimbursement challenges and the fact that back pain is not a life-threatening condition have contributed to this situation, which has been compounded by suppliers\' focus on the fast-growing U.S. market. As a ...[Read More]




Contact Us

Need help finding medtech research? Let us help you!